Bioidentical Hormone Replacement Therapy (BHRT)

"Bioidentical" hormones are molecules chemically identical to the estradiol, progesterone, and testosterone the body makes. Many FDA-approved bioidentical products exist (estradiol patches, micronized progesterone); compounded creams, troches, and pellets are not FDA-approved, and both The Menopause Society and a 2020 National Academies of Sciences, Engineering, and Medicine review recommend FDA-approved products for most patients.

Bioidentical Hormone Replacement Therapy (BHRT)

We track 1124 verified clinics offering Bioidentical Hormone Replacement Therapy (BHRT) across our directory. Across 26 clinics with published pricing, cash-pay BHRT programs report a median range around $199-$399/mo. Nationally, BHRT programs run $1,200–$3,000 per year cash-pay, depending on whether FDA-approved bioidenticals or compounded pellets are used. Average public Google rating across 828 rated clinics: 4.7★ from 47,358 reviews.

Updated 2026-08-15. Cost figures are estimates, not quotes. See the full year-one cost breakdown.

Diagnostic Biomarker & Clinical Prerequisite Summary

How many clinics offer Bioidentical Hormone Replacement Therapy (BHRT)?

Our directory currently tracks 1124 verified clinics offering Bioidentical Hormone Replacement Therapy (BHRT). "Bioidentical" hormones are molecules chemically identical to the estradiol, progesterone, and testosterone the body makes. Many FDA-approved bioidentical products exist (estradiol patches, micronized progesterone); compounded creams, troches, and pellets are not FDA-approved, and both The Menopause Society and a 2020 National Academies of Sciences, Engineering, and Medicine review recommend FDA-approved products for most patients.

Bioidentical vs. compounded — the distinction that matters

"Bioidentical" describes the molecule, not the pharmacy. Estradiol patches, gels, and oral micronized progesterone are bioidentical AND FDA-approved — manufactured with verified dosing, purity, and safety labeling. Compounded BHRT (custom creams, troches, and implanted pellets) is mixed per-prescription and is not FDA-reviewed for safety, efficacy, or dose consistency.

The 2020 National Academies of Sciences, Engineering, and Medicine review concluded there is insufficient evidence to support the broad use of compounded hormones and recommended limiting them to patients who cannot use approved products (for example, a documented allergy to an ingredient). The Menopause Society's 2022 position statement takes the same view. Clinics that only offer compounded pellets deserve extra scrutiny.

What hormone therapy does well

Menopausal hormone therapy remains the most effective treatment available for vasomotor symptoms (hot flashes, night sweats) and genitourinary symptoms, and it prevents menopause-related bone loss. For healthy women under 60 or within 10 years of menopause onset, the benefit-risk profile is generally favorable per The Menopause Society's 2022 position statement.

According to clinical guidelines from The Menopause Society and the American College of Obstetricians and Gynecologists (ACOG), women with an intact uterus need a progestogen alongside estrogen to protect the uterine lining against endometrial hyperplasia. Testosterone is sometimes added for low libido; no FDA-approved female testosterone product exists in the US, so this is off-label and should be dosed conservatively with monitoring.

Risks and who should be cautious

Risks depend on the formulation, dose, route, and when therapy starts. Oral estrogen increases venous blood-clot and stroke risk; transdermal (patch/gel) delivery appears to carry lower clot risk in observational research cited by The Menopause Society. Combined estrogen-progestogen therapy was associated with a small increase in breast cancer risk after roughly 3–5 years of use in the Women's Health Initiative (WHI) randomized trial. Starting hormone therapy more than 10 years after menopause, or after 60, shifts the balance toward risk for many women.

Hormone therapy is generally avoided with a history of breast cancer, estrogen-sensitive cancer, prior blood clots or stroke, active liver disease, or unexplained vaginal bleeding. A legitimate clinic reviews this clinical history before prescribing anything.

What BHRT typically costs

FDA-approved generic estradiol and progesterone are inexpensive — often $30–$100/month cash even without insurance. Longevity-clinic BHRT programs across this directory typically charge $150–$400 for the initial consult and lab panel, then $100–$250/month for ongoing management. Pellet therapy typically runs $350–$500 per insertion for women, repeated every 3–4 months — usually the most expensive route, and the hardest to adjust or discontinue quickly.

How much does Bioidentical Hormone Replacement Therapy (BHRT) cost?

Across 26 clinics with cited published pricing, reported cash prices for BHRT median at $199-$399/mo. FDA-approved generic estradiol and progesterone are inexpensive — often $30–$100/month cash even without insurance. Longevity-clinic BHRT programs across this directory typically charge $150–$400 for the initial consult and lab panel, then $100–$250/month for ongoing management. Pellet therapy typically runs $350–$500 per insertion for women, repeated every 3–4 months — usually the most expensive route, and the hardest to adjust or discontinue quickly.

Which clinics offer Bioidentical Hormone Replacement Therapy (BHRT)?

What clinical guidelines and risks govern Bioidentical Hormone Replacement Therapy (BHRT)?

Important: Compounded hormone preparations (including pellets) are not FDA-approved and are not recommended as first-line therapy by The Menopause Society or the National Academies of Sciences, Engineering, and Medicine. FDA-approved bioidentical options exist for most patients — ask any clinic why they are recommending a compounded product over an approved one. "Bioidentical" describes the molecule, not the pharmacy. Estradiol patches, gels, and oral micronized progesterone are bioidentical AND FDA-approved — manufactured with verified dosing, purity, and safety labeling. Compounded BHRT (custom creams, troches, and implanted pellets) is mixed per-prescription and is not FDA-reviewed for safety, efficacy, or dose consistency. The 2020 National Academies of Sciences, Engineering, and Medicine review concluded there is insufficient evidence to support the broad use of compounded hormones and recommended limiting them to patients who cannot use approved products (for example, a documented allergy to an ingredient). The Menopause Society's 2022 position statement takes the same view. Clinics that only offer compounded pellets deserve extra scrutiny.

Frequently Asked Questions

Are bioidentical hormones safer than 'synthetic' ones?

Not automatically. 'Bioidentical' refers to molecular structure, not safety. FDA-approved bioidentical products (estradiol patches, micronized progesterone) have the strongest evidence. Compounded versions of the same molecules lack FDA review of dose accuracy and safety — the 2020 National Academies review found insufficient evidence to support their widespread use.

What's wrong with hormone pellets?

Pellets deliver supraphysiologic doses in some patients, can't be removed easily if side effects occur, and are not FDA-approved. Professional societies (The Menopause Society, ACOG) recommend FDA-approved delivery methods first. If you choose pellets, insist on baseline and follow-up hormone levels.

How much does BHRT cost per month?

FDA-approved generics can be $30–$100/month. Clinic membership programs typically run $100–$250/month including monitoring. Pellet programs cost $350–$500 per insertion every 3–4 months, plus labs.

What labs are needed before starting?

Typical baseline work includes estradiol, FSH, a thyroid panel, a metabolic panel, and lipids; testosterone and DHEA-S if androgen therapy is being considered. Symptoms — not lab numbers alone — drive menopause treatment decisions per The Menopause Society, so beware clinics selling therapy purely off a hormone panel.

Does BHRT cause breast cancer?

Combined estrogen-progestogen therapy was associated with a small increased breast cancer risk after 3–5+ years of use in the landmark Women's Health Initiative (WHI) trial; estrogen-only therapy (for women without a uterus) did not show the same increase. Absolute risks are small for most healthy women who start near menopause. Review your personal and family history with the prescriber.

How long can I stay on hormone therapy?

There is no fixed mandatory stop date. The Menopause Society 2022 position statement advises periodic re-evaluation of benefits and risks rather than arbitrary discontinuation. Duration should be individualized to symptoms, age, and risk profile.

Can BHRT help with weight gain in menopause?

Hormone therapy is not an FDA-approved weight-loss treatment. It can improve sleep, hot flashes, and body-fat distribution, which indirectly supports weight management, but clinics promising significant weight loss from hormones alone are overselling.

Is telehealth BHRT legitimate?

It can be — estradiol and progesterone are not controlled substances, so telehealth prescribing is more straightforward than TRT. Expect a real clinical history review, baseline labs, and follow-up. Mail-order pellets with no exam are a red flag.

Browse all BHRT clinics

References & Recognized Medical Board Citations

Directory clinical prerequisites, baseline bloodwork guidelines, and treatment protocols listed on VerifiedAntiAgingClinics.com align with published clinical practice guidelines established by recognized national medical boards and professional societies, including the American Board of Obesity Medicine (ABOM), American Board of Urology (ABU), American Board of Internal Medicine - Endocrinology (ABIM), The Endocrine Society, The Menopause Society, and the American Urological Association (AUA).

1. The 2022 Hormone Therapy Position Statement of The North American Menopause Society — Menopause (PubMed)
2. The Clinical Utility of Compounded Bioidentical Hormone Therapy (2020 consensus report) — National Academies of Sciences, Engineering, and Medicine
3. Compounding and the FDA: Questions and Answers — U.S. Food & Drug Administration
4. Women's Health Initiative — study findings and follow-up — Women's Health Initiative (NIH-funded)

Page updated 2026-08-15. Ratings and review counts are aggregated from public Google Business Profiles and are not our own reviews.